Recommended quality control of FFPE samples for Illumina FFPE-supported library preparation kits

03/27/20


Formalin fixed, paraffin embedded (FFPE) extraction methods generally yield highly degraded DNA and RNA, which presents a challenge for library preparation protocols. To determine whether FFPE samples are viable input material for downstream library preparation kit types, Illumina recommends performing FFPE quality control steps.

FFPE-supported library preparation kits and their respective quality control steps:

DNA Sequencing – Whole Exome

Nextera™ Flex for Enrichment

  • All the following are needed to assess sample quality:
    • Infinium™ FFPE QC Kit (Illumina catalog number WG-321-1001) (user supplied)
    • KAPA qPCR MasterMix (Universal) and Primer Premix (user supplied)
    • Bio-Rad CFX96 Touch Real-Time PCR Detection System or equivalent instrument (user supplied)
  • For FFPE samples with ∆Cq value of ≤ 5, the recommended minimum DNA input is ≥ 50 ng.
  • The Nextera Flex for Enrichment kit is not recommended for use with samples with ∆Cq > 5.
  • For extracted FFPE sample input, in the “Amplify Tagmented DNA” step of the library preparation protocol, increase PCR cycles to 12.

TruSeq™ DNA Exome

  • No FFPE QC is required.
    • Adjust FFPE DNA input based on Genomic Quality Number (GQN).
    • To increase library yield for samples with GQN values ≥ 0.3, increase PCR cycles in the first amplification of the protocol to 12 cycles.
  • Increase the amount of each library used for enrichment to 500 ng regardless of initial input amount.
  • For more information regarding the recommendations above, refer to the technical note Evaluating DNA Quality from FFPE Samples.

Targeted DNA Sequencing

AmpliSeq™ for Illumina Panels (fixed panels): BRCA Panel, Cancer Hotspot Panel v2, Childhood Cancer Panel, Comprehensive Panel v3, Comprehensive Cancer Panel, Focus Panel, and TCR beta-SR Panel

AmpliSeq for Illumina Custom DNA Panel (custom panel)

  • No FFPE QC is required for the AmpliSeq kits.
  • Do not exceed the maximum supported amount of input DNA.
  • Use 1 ng DNA only with high-quality, well-quantified samples.

TruSight™ Tumor 15 (fixed panels)

  • No FFPE QC is required.
    • Use at least 140 mm2 of nonmelanoma tissues with at least 30% tumor content.
    • Use a validated FFPE extraction kit:
      • AllPrep DNA/RNA FFPE kit (QIAGEN)
      • QIAamp DSP DNA FFPE tissue kit (QIAGEN)
      • ReliaPrep FFPE gDNA MiniPrep System (Promega)
  • For more information, refer to the FFPE DNA Extraction section of the TruSight Tumor 15 Reference Guide.

RNA Sequencing – whole transcriptome / exome

TruSeq Stranded Total RNA

  • Assess FFPE RNA quality by 2100 Bioanalyzer Desktop System (Agilent Technologies, part # G2940CA) with Agilent RNA 6000 Nano Kit (part # 5067-1511).
  • Or assess FFPE RNA quality by Fragment Analyzer Automated CE System (Advanced Analytical Technologies, part # FSv2-CE2 or FSv2-CE10) with Standard Sensitivity RNA Analysis Kit (20nt Lower Marker) (Advanced Analytical Technologies, part # DNF-489).
  • Adjust fragmentation time according to the Modify RNA Fragmentation Time for Degraded RNA section of the TruSeq Stranded Total RNA Sample Preparation Guide.

TruSeq RNA Exome

  • Adjust FFPE RNA input amount based on DV200 values, which is the percentage of RNA fragments > 200 nucleotides, calculated with the BioAnalzyer or the Fragment Analyzer. By adjusting RNA input amounts, high-quality libraries can be prepared from poor-quality FFPE samples.
  • For more information, see the technical note Evaluating RNA Quality from FFPE Samples.

Targeted RNA Sequencing – Fixed and Custom Panels

TruSight Pan Cancer

TruSight RNA Fusion

AmpliSeq™ for Illumina Panels: Transcriptome Human Gene Expression Panel, Exome Panel, Immune Repertoire Plus, TCR beta Panel, and Immune Response Panel

AmpliSeq for Illumina custom RNA Panel

  • Each reverse transcription reaction requires 1–100 ng of DNase-treated total RNA. The recommended input is 10 ng RNA.
  • Use 1 ng total RNA only with high-quality, well-quantified samples. Do not use a UV-spectrometer-based method.
  • Library yield can be lower for degraded library samples such as FFPE RNA.

Targeted DNA/ RNA Sequencing – Fixed Panels

TruSight Tumor 170

  • To obtain sufficient nucleic acid material, we recommend isolating nucleic acid from a minimum of 2 mm3 of FFPE tissue.
  • Input may need to be adjusted based on FFPE quality. For more information, please see the white paper Assessing DNA and RNA Quality from FFPE Samples for TruSight® Tumor 170.
  • QIAGEN AllPrep DNA/RNA FFPE Kit is suggested for nucleic extraction.
  • DNA
    • Illumina FFPE QC kit (WG-321-1001) is recommended to check FFPE sample quality.
    • Recommend the use of DNA samples with ∆Cq value ≤ 5. Samples with a ∆Cq > 5 can decrease assay performance.
  • RNA
    • RNA sample quality can be assessed using Advanced Analytical Technologies Fragment Analyzer™ (Standard Sensitivity RNA Analysis Kit) or Agilent Technologies 2100 Bioanalyzer (Agilent RNA 6000 Nano Kit).
    • Recommend the use of RNA samples that have a DV200 value of ≥ 20%. Using samples with a DV200 value < 20% may decrease assay performance.

TruSight Oncology 500

  • To obtain sufficient nucleic acid material, we recommend isolating DNA from a minimum of 2 mm3 of FFPE tissue.
    • QIAGEN AllPrep DNA/RNA FFPE Kit is recommended for DNA extraction.
  • Illumina FFPE QC kit (WG-321-1001) is recommended to check FFPE sample quality.
  • Recommend use of DNA samples with ∆Cq value ≤ 5. Samples with a ∆Cq > 5 can decrease assay performance.

The above summarizes the quality control requirements and recommendations for use of FFPE samples with FFPE-supported library preparation kits. For more information, see the support page for each library preparation kit. For more information on FFPE DNA qualification, see the Infinium HD FFPE QC Assay Protocol.